本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immunome Inc.

22.21
+0.20000.91%
盘后22.660.4492+2.02%19:34 EDT
成交量:61.52万
成交额:1,364.67万
市值:25.10亿
市盈率:-9.44
高:22.42
开:22.13
低:21.61
收:22.01
52周最高:27.65
52周最低:8.67
股本:1.13亿
流通股本:1.08亿
量比:0.76
换手率:0.57%
股息:- -
股息率:- -
每股收益(TTM):-2.3519
每股收益(LYR):-2.4315
净资产收益率:-50.14%
总资产收益率:-29.72%
市净率:4.26
市盈率(LYR):-9.13

数据加载中...

2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]